These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

216 related items for PubMed ID: 19693649

  • 1. IRF4 selectively controls cytokine gene expression in chronic intestinal inflammation.
    Mudter J, Yu J, Amoussina L, Weigmann B, Hoffman A, Rücknagel K, Galle PR, Neurath MF.
    Arch Immunol Ther Exp (Warsz); 2009; 57(5):369-76. PubMed ID: 19693649
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. The transcription factor IFN regulatory factor-4 controls experimental colitis in mice via T cell-derived IL-6.
    Mudter J, Amoussina L, Schenk M, Yu J, Brüstle A, Weigmann B, Atreya R, Wirtz S, Becker C, Hoffman A, Atreya I, Biesterfeld S, Galle PR, Lehr HA, Rose-John S, Mueller C, Lohoff M, Neurath MF.
    J Clin Invest; 2008 Jul; 118(7):2415-26. PubMed ID: 18535667
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Blockage of tumor necrosis factor prevents intestinal mucosal inflammation through down-regulation of interleukin-23 secretion.
    Liu Z, Jiu J, Liu S, Fa X, Li F, Du Y.
    J Autoimmun; 2007 Jul; 29(2-3):187-94. PubMed ID: 17804196
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. A critical role of CD30 ligand/CD30 in controlling inflammatory bowel diseases in mice.
    Sun X, Somada S, Shibata K, Muta H, Yamada H, Yoshihara H, Honda K, Nakamura K, Takayanagi R, Tani K, Podack ER, Yoshikai Y.
    Gastroenterology; 2008 Feb; 134(2):447-58. PubMed ID: 18242212
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Inducible IL-12-producing B cells regulate Th2-mediated intestinal inflammation.
    Sugimoto K, Ogawa A, Shimomura Y, Nagahama K, Mizoguchi A, Bhan AK.
    Gastroenterology; 2007 Jul; 133(1):124-36. PubMed ID: 17631137
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Interleukin-25 inhibits interleukin-12 production and Th1 cell-driven inflammation in the gut.
    Caruso R, Sarra M, Stolfi C, Rizzo A, Fina D, Fantini MC, Pallone F, MacDonald TT, Monteleone G.
    Gastroenterology; 2009 Jun; 136(7):2270-9. PubMed ID: 19505427
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Muramyl dipeptide activation of nucleotide-binding oligomerization domain 2 protects mice from experimental colitis.
    Watanabe T, Asano N, Murray PJ, Ozato K, Tailor P, Fuss IJ, Kitani A, Strober W.
    J Clin Invest; 2008 Feb; 118(2):545-59. PubMed ID: 18188453
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Cytokine expression and the role of Thl7 cells in mice colitis.
    He Y, Lin LJ, Zheng CQ, Jin Y, Lin Y.
    Hepatogastroenterology; 2012 Sep; 59(118):1809-13. PubMed ID: 23115792
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.